Drug General Information
Drug ID	D0C8JY
Drug Name	Rociletinib
Indication	Lung Cancer [ICD10:C33-C34]		Phase 3	[1572594]
Structure		Download 2D MOL 3D MOL
Drug Resistance Mutation (DRM)
DRM	DRM Info
References
Ref 1572594	ClinicalTrials.gov (NCT02322281) TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.